Dean Tuck – Managing Director – Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
Copyright 2024 – Finance News Network
30 November 2022 - James Powell, the General Manager - Investor Relations, Corporate Affairs and Sustainability of the Rural Funds Group Limited (ASX:RFF) presents on the group's FY22 financial results.
25 Nov 2020 - Melbana Energy (ASX:MAY) Executive Chairman Andrew Purcell provides an update on its portfolio with particular focus on its onshore Cuban project Block 9, the potential size of the field, drilling program and funding.
05 May 2022 - Torian Resources Limited (ASX:TNR) Executive Chairman Paul Summers and Senior Geologist Claudio Sheriff discuss the significance of the company's rare earths discovery.
10 Oct 2023 - Cameron Perks - Principal Analyst - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
12 Feb 2020 - Mayur Resources Limited (ASX:MRL) Managing Director, Paul Mulder provides an update on the company's PNG projects, which span industrial minerals, power generation, coal, copper and gold.
24 Feb 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the sectors to invest in given slowing global growth, tightening financial conditions, the risk of inflation and geopolitical imbalances.
25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Juan Pablo Vargas de la Vega, Managing Director of Galan Lithium (ASX:GLN).
16 Aug 2023 - Yoav Amitai - CEO - Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
14 Oct 2024 - Weebit Nano Limited (ASX:WBT) Chairman Dadi Perlmutter discusses the company's innovative ReRAM technology as a superior alternative to flash memory. ReRAM has huge market potential, usable in devices from cars to smartphones.
20 Sep 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the FDA's award of orphan status and rare paediatric disease designation for the company's DUNP19 technology.